Capricor Therapeutics | CAPR - Cash And Equivalent


Capricor Therapeutics reported $19.51M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Alterity Therapeutics Limited AUD 15.77M 9.56M Jun/2023
Bioline Rx USD 7.91M 725K Sep/2025
Capricor Therapeutics USD 19.51M 3.73M Sep/2025
Cipla INR 7.96B 39.9M Sep/2025
Cytokinetics USD 122.52M 102.95M Dec/2025
Geron USD 79.44M 553K Dec/2025
Grifols EUR 979.78M 334.84M Dec/2024
Immunic USD 35.13M 20.18M Sep/2025
J&J USD 19.71B 1.48B Dec/2025
Plus Therapeutics USD 8.55M 2.45M Dec/2023
Prothena USD 330.84M 40.6M Sep/2025
PTC Therapeutics USD 984.65M 312.03M Dec/2025
Sarepta Therapeutics USD 801.28M 188.2M Dec/2025